DSM at a glance

Overview of our business & performance

A broad, global nutrition business and a focused, high-quality, specialty materials portfolio

Royal DSM is a global purpose-led, science-based company in Nutrition, Health and Sustainable Living. DSM’s purpose is to create brighter lives for all. With its products and solutions DSM addresses some of the world’s biggest challenges whilst creating simultaneously economic, environmental and societal value for all its stakeholders; customers, employees, shareholders, and society-at-large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam.

2020 key data

Group

€8,106m

Net sales

€7,998 in 2019

€1,534m

Adjusted EBITDA

€1,551 in 2019

18.9%

Adjusted EBITDA margin

19.4% in 2019

Nutrition

€6,365m

Net sales

€6,028 in 2019. >80% of group net sales

€1,338m

Adjusted EBITDA

€1,250 in 2019

21.0%

Adjusted EBITDA margin

20.7% in 2019 & an ambition of >20%

Materials

€1,518m

Net sales

€1,744 in 2019

€272m

Adjusted EBITDA

€372 in 2019

17.9%

Adjusted EBITDA margin

21.3% in 2019

People

0.24

Frequency Index of Recordable Injuries

0.28 in 2019

76%

Employee Engagement Index

74% in 2019

21%

Female executives

20% in 2019

29:71

Female:male ratio

28:72 in 2019

75%

Inclusion Index

72% in 2019

100%

Employees

offered immunity-optimizing supplements

Planet

25%

Absolute reduction

Scope 1 + 2 GHG emissions (2016 baseline)

~18%

Structural improvement

Scope 1 + 2 GHG emissions (2016 baseline)

5%

Intensity improvement

Scope 3 GHG emissions (2016 baseline)

60%

Purchased electricity

From renewable resources

5.7%

Energy efficiency

Improvement year-on-year

4.8%

Water efficiency

Improvement year-on-year

Profit

↑24%

Total Shareholder Return

vs. 2019

↑1%

Sales

continuing operations vs. 2019

↓1%

Adjusted EBITDA

continuing operations vs. 2019

€955m

Adjusted net operating free cash flow

€457m

Net profit from continuing operations

€2.40

Proposed dividend per ordinary share

Latest financial & regulatory news

Managing Board

Geraldine Matchett, Co-CEO

Geraldine Matchett is Co-Chief Executive Officer, Chief Financial Officer and Member of the Managing Board. She was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2014. Her current term will end in 2022.

Dimitri de Vreeze, Co-CEO

Dimitri de Vreeze is Co-Chief Executive Officer, Chief Operating Officer and Member of the Managing Board. He was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2013. His current term will end in 2021.

Read more

  • Factbooks

    DSM's Factbook provides investors and analysts with an introduction to the company and our key individual businesses.